DRUG
DRUG
NASDAQ · Biotechnology

Bright Minds Biosciences Inc

$60.98
-0.57 (-0.93%)
As of Sep 20, 10:16 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -55.8% upside
Low Target $16.82
Average Target $26.95
High Target $32.06
Current Price $60.98
Current
$60.98
Target
$26.95
$16.82 $26.95 avg $32.06
Scenario Analysis
Bear Case
$16.82
-72.4%
Low target
Base Case
$26.95
-55.8%
Avg target
Bull Case
$32.06
+-47.4%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$170.00
-64.1% from high
52-Week Low
$64.62
+-5.6% from low
Target vs 52W High
$26.95
-84.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%